| Mepha Pharma AG - Olanzapin-Mepha Teva oro 15 mg, Schmelztabletten |
| 58624 | | 05 | | Olanzapin-Mepha Teva oro 15 mg | | Schmelztabletten | | N05AH03 | | Olanzapine | | 26.11.2009 | | |
|
| Composition |
| olanzapinum 15 mg, mannitolum 207 mg, magnesii stearas, crospovidonum, lactosum monohydricum 150 mg, hydroxypropylcellulosum substitutum humile, aromatica (Zitrone) cum saccharum 0.792 mg et aspartamum 6.75 mg, pro compresso. |
| Packungsbestandteile |
| Melting tablets | | | | Active Agent | Dose |
|---|
| Olanzapine | 15 mg |
| | | | Inactive agents | Dose |
|---|
| Aromatica (Zitrone) cum Saccharum | 0.792 mg | | Aspartame | 6.75 mg | | Crospovidonum | | | Hydroxypropylcellulosum Substitutum Humile | | | Lactose Monohydrate | 150 mg | | Magnesii Stearas | | | Mannitol | 207 mg | | Pro Compresso | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 016 | 30 | PR | PR | B | | No | | 017 | 100 | PR | PR | B | | No |
|
